Calpine Corp (CPN) 13.25 $CPN Champion Energy Services

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Calpine Corp (CPN) 13.25 $CPN

Champion Energy Services to Supply 100% Renewable Energy Certificates for the 2016 US Open Tennis Tournament
BusinessWire - Mon Aug 01, 10:15AM CDT
Champion Energy Services, a subsidiary of Calpine Corporation (NYSE: CPN), the electricity supplier to the USTA Billie Jean King National Tennis Center, announced today it will be donating Green-e Energy certified renewable energy certificates (RECs) to match the electricity used during the 2016 US Open, the highest-attended annual sporting event in the world.
CPN: 13.25 (-0.18)

SmarTrend Watching for Potential Rebound in Shares of Calpine After 4.71% Loss
Comtex SmarTrend(R) - Fri Jul 29, 1:54PM CDT
Calpine (NYSE:CPN) traded in a range yesterday that spanned from a low of $13.32 to a high of $14.38. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $13.96 on volume of 6.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CPN: 13.25 (-0.18)

Calpine Falls 4.71% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Jul 29, 1:52PM CDT
Calpine (NYSE:CPN) traded in a range yesterday that spanned from a low of $13.32 to a high of $14.38. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $13.96 on volume of 6.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CPN: 13.25 (-0.18)

Calpine Reports Second Quarter Results, Narrows 2016 Guidance
BusinessWire - Fri Jul 29, 5:00AM CDT
Calpine Corporation (NYSE: CPN):
CPN: 13.25 (-0.18)

Duke Energy Gets Nod to Build 17MW Solar Plant in Indiana
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 9:22AM CDT
Duke Energy Corporation (DUK) has received approval from the Indiana Utility Regulatory Commission on a settlement agreement involving the company and the Indiana Office of Utility Consumer Counselor.
CPN: 13.25 (-0.18), DUK: 85.40 (-0.25), DTE: 98.20 (+0.02), SPKE: 24.36 (-0.19)

U.S. Geothermal Shifts Gears To Aggressive Growth
ACCESSWIRE - Wed Jul 06, 7:39AM CDT
REDONDO BEACH, CA / ACCESSWIRE / July 6, 2016 / This undervalued New York Stock Exchange company has consistently under promised and over delivered the kind of growth that savvy and risk averse investors are always searching for; and after more than 2 years of planning and building a larger and stronger foundation, management is now moving forward to accelerate growth with the goal to become a billion dollar market cap company in the fast growing renewable energy sector.
TSLA: 225.57 (-4.44), GE: 31.04 (-0.11), CPN: 13.25 (-0.18), HTM: 0.82 (-0.01), CLD: 3.25 (-0.13), CAFD: 16.32 (-0.12), AXAS: 1.13 (+0.01), FSLR: 47.34 (-0.04), GS: 155.94 (-2.24), SCTY: 24.26 (-0.46), SKYS: 2.75 (+0.21), XCO: 1.28 (-0.08), ALJ: 6.79 (+0.12)

Pre-Market Scans on Electric Utilities Stocks -- Calpine, Xcel Energy, Duke Energy, and American Electric Power
PR Newswire - Wed Jun 15, 7:30AM CDT
On Tuesday, June 14, 2016, the NASDAQ Composite ended the trading session at 4,843.55, down 0.10%; the Dow Jones Industrial Average edged 0.33% lower to finish at 17,674.82; and the S&P 500 closed at 2,075.32, down 0.18%. Stock-Callers.com has initiated coverage on the following equities: Calpine Corporation (NYSE: CPN), Xcel Energy Inc. (NYSE: XEL), Duke Energy Corporation (NYSE: DUK), and American Electric Power Company Inc. (NYSE: AEP). Learn more about these stocks by accessing their free trade alerts at:
AEP: 68.96 (-0.35), XEL: 43.77 (-0.17), CPN: 13.25 (-0.18), DUK: 85.40 (-0.25)

Calpine Falls 1.12% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jun 14, 3:39PM CDT
Calpine (NYSE:CPN) traded in a range yesterday that spanned from a low of $13.93 to a high of $14.37. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $14.13 on volume of 3.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CPN: 13.25 (-0.18)

Fitch Rates Calpine's New First-Lien Term Loan and Sr Secured Notes 'BB+'
BusinessWire - Tue Jun 07, 1:37PM CDT
Fitch Ratings has assigned a 'BB+' rating to Calpine Corp.'s $562 million first-lien term loan facility maturing May 31, 2023 and $625 million 5.25% senior secured notes due June 1, 2026. The term loan amortizes at 1% per year and is priced at L+300 basis points. The new term loan and the 2026 senior secured notes are secured equally and ratably by a first-priority lien on substantially all of Calpine's and certain of its guarantors existing and future assets. The new financings are pari passu with Calpine's existing first-lien debt including the revolving credit facility. Fitch has assigned a Recovery Rating (RR) of 'RR1' (implying 91% - 100% recovery) to the new financings. The Rating Outlook is Stable.
CPN: 13.25 (-0.18)

Calpine to Participate at the RBC Capital Markets' Global Energy and Power Executive Conference
BusinessWire - Fri Jun 03, 3:15PM CDT
Trey Griggs, Chief Commercial Officer, and Zamir Rauf, Chief Financial Officer, of Calpine Corporation (NYSE:CPN), will meet with institutional investors at the RBC Capital Markets' Global Energy and Power Executive Conference June 6, 2016, in New York City.
CPN: 13.25 (-0.18)

Calpine Corporation Announces Closings of Senior Secured Notes Offering and Term Loan Facility
BusinessWire - Tue May 31, 3:15PM CDT
Calpine Corporation (NYSE: CPN) today announced the closing of $1,187,000,000 of financings, including its previously disclosed private placement of $625,000,000 in aggregate principal amount of 5.250% Senior Secured Notes due 2026 and its $562,000,000 first lien term loan facility maturing in May 2023. The principal amount of the new term loan facility was increased from $500,000,000.
CPN: 13.25 (-0.18)

Calpine Corporation Announces Upsizing and Pricing of Senior Secured Notes Offering
BusinessWire - Tue May 24, 5:32PM CDT
Calpine Corporation (NYSE:CPN) today announced the pricing of $625,000,000 in aggregate principal amount of its 5.250% Senior Secured Notes due 2026 in a private placement. The aggregate principle amount of the notes offered was increased from $500,000,000. The offering is expected to close on May 31, 2016.
CPN: 13.25 (-0.18)

Calpine Corporation Announces Senior Secured Notes Offering
BusinessWire - Tue May 24, 10:08AM CDT
Calpine Corporation (NYSE:CPN) today announced that it intends to offer $500,000,000 in aggregate principal amount of Senior Secured Notes due 2026 in a private placement. The notes will be guaranteed by each of Calpine Corporation's current and future subsidiaries that is a guarantor under Calpine Corporation's first lien credit facilities. The notes and related guarantees will be secured equally and ratably with the indebtedness incurred under Calpine Corporation's first lien credit facilities and other indebtedness that is permitted to be secured by such assets, by a first-priority lien on substantially all of Calpine Corporation's and certain of the guarantors' existing and future assets, subject to certain exceptions and permitted liens.
CPN: 13.25 (-0.18)

Cheniere Energy names Jack Fusco as CEO
AP - Thu May 12, 9:20AM CDT
NEW YORK (AP) — Cheniere Energy has named Jack Fusco as CEO after the natural gas company's previous CEO was forced out under pressure from activist investor Carl Icahn.
CPN: 13.25 (-0.18)

Frank Cassidy Elected Chairman of Calpine Corporation Board of Directors
BusinessWire - Thu May 12, 7:15AM CDT
Calpine Corporation (NYSE:CPN) announced today that following its Annual Meeting of Shareholders yesterday, the Board of Directors elected Frank Cassidy as Chairman of the Board.
CPN: 13.25 (-0.18), PEG: 44.95 (-0.44)

Cheniere Energy, Inc. Announces Appointment of Jack A. Fusco as President and Chief Executive Officer
PR Newswire - Thu May 12, 7:00AM CDT
Cheniere Energy, Inc. ("Cheniere" (NYSE MKT: LNG) announced today that its Board of Directors has appointed Jack A. Fusco as President and Chief Executive Officer, effective immediately. Mr. Fusco succeeds Neal A. Shear, who has served as Cheniere's interim President and Chief Executive Officer since December 2015. Mr. Fusco joins Cheniere from Calpine Corporation, where he most recently served as Executive Chairman of the Board of Directors.
CPN: 13.25 (-0.18), LNG: 38.87 (-0.50)

Short Interest In Calpine Decreases By 21.3%
MarketNewsVideo.com - Mon May 02, 2:33PM CDT
The most recent short interest data has been released for the 04/15/2016 settlement date, which shows a 3,585,199 share decrease in total short interest for Calpine Corp , to 13,232,984.0, a decrease of 21.32% since 03/31/2016. Total short interest...
CPN: 13.25 (-0.18)

Calpine Reports First Quarter Results, Reaffirms 2016 Guidance
BusinessWire - Fri Apr 29, 5:00AM CDT
Calpine Corporation (NYSE: CPN):
CPN: 13.25 (-0.18)

Fitch Affirms Calpine's Ratings at 'B+'; Outlook Stable
BusinessWire - Tue Apr 26, 4:09PM CDT
Fitch Ratings has affirmed Calpine Corp.'s Long-term Issuer Default Rating (IDR) at 'B+'. The Rating Outlook is Stable. Fitch has affirmed Calpine's first lien senior secured debt at 'BB+' with a Recovery Rating (RR) of 'RR1' (implying 91% - 100% recovery). The first lien senior secured debt includes first lien term loans, first lien senior secured notes and the revolving credit facility, all of which are pari passu. Fitch has also affirmed Calpine's senior unsecured debt at 'BB-/RR3'. The 'RR3' rating implies a 51% - 70% recovery.
CPN: 13.25 (-0.18)

FirstEnergy Unit Files for Approval of Energy Efficiency Plan
A Clark - Zacks Investment Research - Mon Apr 18, 1:24PM CDT
FirstEnergy Corporation's (FE) Ohio utilities have sought approval from the Public Utilities Commission of Ohio for its proposed Energy Efficiency and Peak Demand Reduction Portfolio Plans
AT: 2.49 (-0.01), CPN: 13.25 (-0.18), FE: 33.56 (-0.75), BKH: 63.15 (-0.38)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading